Clinical Neuroimmunology
About
Organisation:
Working group head:
Country:
Berlin, Germany
Research types:
Clinical research, Basic research, Epidemiological research
Link
Website
Description
Multiple sclerosis (MS) is the most frequent chronic inflammatory disease of the central nervous system and primarily affects young adults. The course taken by MS varies greatly between individuals, and cannot be predicted well in individual patients. One of the group's fields of activity is the development and establishing of new progress and prognosis markers. These include, for example, improvements in the field of magnetic resonance imaging (MRI), e.g. ultra-high-field MRI and also the establishing of new imaging procedures such as optical coherence tomography (OCT). (Description adapted from working group website: see link above)Research projects
4
Research areas
14
Research types
5
Research networks
2
People
4
Research projects
Biosamples, GPCR-Autoantibodies, Data Management and Bioinformatics
Project status:
OngoingCountry:
GermanyPrincipal investigator:
Uta Behrends
Organisations:
University Hospital rechts der Isar (MRI TUM), Technical University of Munich (TUM)
Research period:
2022-08
to 2025-07
to 2025-07
Research types:
Basic research
Research areas:
Immune system dysfunction, General
Care Model for Patients with ME/CFS (CFS_CARE)
Project status:
OngoingCountry:
GermanyPrincipal investigator:
Carmen Scheibenbogen
Organisations:
Charité – University Medicine Berlin
Research period:
2021-12
to 2024-12
to 2024-12
Research types:
Epidemiological research
Research areas:
General, Mental health
Endothelial Dysfunction and Altered Endothelial Biomarkers in Patients with Post-COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS)
Project status:
CompletedCountry:
GermanyPrincipal investigator:
Milan Haffke
Organisations:
Charité – University Medicine Berlin
Research period:
Not available
Research types:
Clinical research
Research areas:
Cardiovascular system dysfunction
Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome (VERI-LONG)
Project status:
OngoingCountry:
GermanyPrincipal investigator:
Judith Bellmann-Strobl
Organisations:
Charité – University Medicine Berlin, Max Delbrück Center (MDC)
Research period:
2023-02
to 2024-12
to 2024-12
Research types:
Clinical research
Research areas:
Cardiovascular system dysfunction
Contact
ME/CFS Research Foundation
Ballindamm 27, 20095 Hamburg, Germany
Copyright © 2022 ME/CFS Research Foundation
Imprint -
Data privacy statement